Literature DB >> 22778398

Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence.

David J Elzi1, Yanlai Lai, Meihua Song, Kevin Hakala, Susan T Weintraub, Yuzuru Shiio.   

Abstract

Cellular senescence is widely believed to play a key role in tumor suppression, but the molecular pathways that regulate senescence are only incompletely understood. By using a secretome proteomics approach, we identified insulin-like growth factor binding protein 3 (IGFBP3) as a secreted mediator of breast cancer senescence upon chemotherapeutic drug treatment. The senescence-inducing activity of IGFBP3 is inhibited by tissue-type plasminogen activator-mediated proteolysis, which is counteracted by plasminogen activator inhibitor 1 (PAI-1), another secreted mediator of senescence. We demonstrate that IGFBP3 is a critical downstream target of PAI-1-induced senescence. These results suggest a role for an extracellular cascade of secreted proteins in the regulation of cellular senescence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22778398      PMCID: PMC3409757          DOI: 10.1073/pnas.1120437109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Human pregnancy serum contains at least two distinct proteolytic activities with the ability to degrade insulin-like growth factor binding protein-3.

Authors:  P Bang; P J Fielder
Journal:  Endocrinology       Date:  1997-09       Impact factor: 4.736

Review 2.  The essence of senescence.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

3.  Differential growth state-dependent regulation of plasminogen activator inhibitor type-1 expression in senescent IMR-90 human diploid fibroblasts.

Authors:  X C Mu; P J Higgins
Journal:  J Cell Physiol       Date:  1995-12       Impact factor: 6.384

4.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

5.  Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of senescent and quiescent human fibroblasts.

Authors:  S Goldstein; E J Moerman; R A Jones; R C Baxter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

6.  Diverse gene sequences are overexpressed in werner syndrome fibroblasts undergoing premature replicative senescence.

Authors:  S Murano; R Thweatt; R J Shmookler Reis; R A Jones; E J Moerman; S Goldstein
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

7.  Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53.

Authors:  C Kunz; S Pebler; J Otte; D von der Ahe
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

8.  Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression.

Authors:  John W M Martens; Anieta M Sieuwerts; Joan Bolt-deVries; Peter T Bosma; Susan J J Swiggers; Jan G M Klijn; John A Foekens
Journal:  Thromb Haemost       Date:  2003-02       Impact factor: 5.249

Review 9.  Hallmarks of senescence in carcinogenesis and cancer therapy.

Authors:  Jerry W Shay; Igor B Roninson
Journal:  Oncogene       Date:  2004-04-12       Impact factor: 9.867

10.  Induction of the growth inhibitor IGF-binding protein 3 by p53.

Authors:  L Buckbinder; R Talbott; S Velasco-Miguel; I Takenaka; B Faha; B R Seizinger; N Kley
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

View more
  58 in total

Review 1.  Cellular Senescence: The Trojan Horse in Chronic Lung Diseases.

Authors:  Shruthi Hamsanathan; Jonathan K Alder; Jacobo Sellares; Mauricio Rojas; Aditi U Gurkar; Ana L Mora
Journal:  Am J Respir Cell Mol Biol       Date:  2019-07       Impact factor: 6.914

2.  Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.

Authors:  Amarnath S Marudamuthu; Shwetha K Shetty; Yashodhar P Bhandary; Sophia Karandashova; Michael Thompson; Venkatachalem Sathish; Galina Florova; Taryn B Hogan; Christina M Pabelick; Y S Prakash; Yoshikazu Tsukasaki; Jian Fu; Mitsuo Ikebe; Steven Idell; Sreerama Shetty
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

3.  Switching off IMMP2L signaling drives senescence via simultaneous metabolic alteration and blockage of cell death.

Authors:  Lifeng Yuan; Linhui Zhai; Lili Qian; Yi Ding; Handan Xiang; Xiaojing Liu; J Will Thompson; Juan Liu; Yong-Han He; Xiao-Qiong Chen; Jing Hu; Qing-Peng Kong; Minjia Tan; Xiao-Fan Wang
Journal:  Cell Res       Date:  2018-05-28       Impact factor: 25.617

4.  Antitumor activity and immunogenicity of recombinant vaccinia virus expressing HPV 16 E7 protein SigE7LAMP is enhanced by high-level coexpression of IGFBP-3.

Authors:  J Musil; L Kutinova; K Zurkova; P Hainz; K Babiarova; J Krystofova; S Nemeckova
Journal:  Cancer Gene Ther       Date:  2014-02-21       Impact factor: 5.987

5.  Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis.

Authors:  Namiko Kobayashi; Toshiharu Ueno; Kumi Ohashi; Hanako Yamashita; Yukina Takahashi; Kazuo Sakamoto; Shun Manabe; Satoshi Hara; Yasutoshi Takashima; Takashi Dan; Ira Pastan; Toshio Miyata; Hidetake Kurihara; Taiji Matsusaka; Jochen Reiser; Michio Nagata
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

6.  Autolysosome biogenesis and developmental senescence are regulated by both Spns1 and v-ATPase.

Authors:  Tomoyuki Sasaki; Shanshan Lian; Alam Khan; Jesse R Llop; Andrew V Samuelson; Wenbiao Chen; Daniel J Klionsky; Shuji Kishi
Journal:  Autophagy       Date:  2016-11-22       Impact factor: 16.016

Review 7.  Senescent cells: an emerging target for diseases of ageing.

Authors:  Bennett G Childs; Martina Gluscevic; Darren J Baker; Remi-Martin Laberge; Dan Marquess; Jamie Dananberg; Jan M van Deursen
Journal:  Nat Rev Drug Discov       Date:  2017-07-21       Impact factor: 84.694

8.  PAI-1-regulated extracellular proteolysis governs senescence and survival in Klotho mice.

Authors:  Mesut Eren; Amanda E Boe; Sheila B Murphy; Aaron T Place; Varun Nagpal; Luisa Morales-Nebreda; Daniela Urich; Susan E Quaggin; G R Scott Budinger; Gökhan M Mutlu; Toshio Miyata; Douglas E Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

9.  Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nω-nitro-L-arginine methyl ester-induced hypertension and vascular senescence.

Authors:  Amanda E Boe; Mesut Eren; Sheila B Murphy; Christine E Kamide; Atsuhiko Ichimura; David Terry; Danielle McAnally; Layton H Smith; Toshio Miyata; Douglas E Vaughan
Journal:  Circulation       Date:  2013-10-03       Impact factor: 29.690

10.  Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome.

Authors:  Hekmat B Khoukaz; Yan Ji; Drew J Braet; Manisha Vadali; Ahmed A Abdelhamid; Cory D Emal; Daniel A Lawrence; William P Fay
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-04-09       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.